Lincoln Pharmaceuticals consolidated net profit rises 22.78% in the December 2022 quarter
Sales rise 11.59% to Rs 133.77 crore
Net profit of Lincoln Pharmaceuticals rose 22.78% to Rs 21.61 crore in the quarter ended December 2022 as against Rs 17.60 crore during the previous quarter ended December 2021. Sales rose 11.59% to Rs 133.77 crore in the quarter ended December 2022 as against Rs 119.88 crore during the previous quarter ended December 2021. ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales133.77119.88 12 OPM %20.0019.56 -PBDT32.7825.78 27 PBT30.5123.60 29 NP21.6117.60 23Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 09 2023 | 2:27 PM IST